Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Tecan Provides Automated Solutions for Molecular Pharmacology

Published: Tuesday, July 06, 2010
Last Updated: Thursday, July 15, 2010
Bookmark and Share
Leibniz-Institut uses Tecan’s Freedom EVO® workstations for systematic high throughput screening of bioactive small molecule libraries.

The Leibniz-Institut fur Molekulare Pharmakologie in Berlin, Germany, is using Tecan’s Freedom EVO® workstations for systematic high throughput screening of bioactive small molecule libraries, looking for potential research tools and targets for drug development.

Dr Jens Peter von Kries, Head of the Institute’s Screening Unit, explained: “The Screening Unit has a small team of staff performing library screens of around 20,000 compounds a day, and this high throughput is partly thanks to the flexibility of our Freedom EVO workstations. Many of our projects use either high content screening with automated microscopes or genome-wide RNA interference (RNAi) studies, and we have a Freedom EVO system configured for each of these methods, as well as a platform equipped with a REMP Small Size Store™ for management of the ChemBioNet screening library.”

“Each workstation has been collaboratively designed with the Tecan Integration Group (TIG) to create a robust system that is capable of high throughput analysis, giving consistent results even with long term use. The approval procedure is central to this process, with both factory and site acceptance tests to guarantee that the platform exactly matches our needs. Tecan is very willing to support us with development of the platforms as new technologies become available, and we enjoy a very good working relationship with the company’s automation engineers, receiving immediate expert support for all our projects. Tecan has an exceptional culture of customer service, and our work here at the FMP undoubtedly benefits from this close partnership.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Screening Center Chooses Tecan for Reliability and Support
The University of Chicago’s CSC is using Tecan’s Freedom EVO® workstations to provide high throughput cell screening services.
Friday, June 11, 2010
Tecan Platforms Improve Microarray Throughput and Research Quality in South Africa
South African researchers have established a high throughput biological research platform with a number of automated microarray processing systems from Tecan.
Friday, February 22, 2008
High Throughput Screening of Infectious Virus Entry in Mammalian Cells
Researchers at Swiss Federal Institute of Technology are using two customized Tecan Freedom EVO® 200 liquid handling workstations to silence 7,000 mammalian genes.
Thursday, June 07, 2007
Tecan Boosts RNA Work in France
Tecan's Freedom EVO® Workstation has been used to develop automated in vitro selection techniques for identifying and isolating aptamers.
Wednesday, March 29, 2006
Scientific News
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Cancer Cells Coordinate to Form Roving Clusters
Rice University scientists identify ‘smoking gun’ in metastasis of hybrid cells.
Poliovirus Therapy Wins 'Breakthrough' Status
FDA decision will fast-track research on breakthrough Duke brain cancer therapy.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
New Treatment for Pancreatic Cancer
Researchers at Purdue University have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!